📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Acambis

1.1 - Company Overview

Acambis Logo

Acambis

Headquarter: United Kingdom
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of vaccine research, development and manufacturing for the prevention and treatment of infectious diseases in Europe and North America, offering ACAM2000, a smallpox vaccine for emergency-use stockpiling, and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Acambis

X-Body Biosciences Logo

X-Body Biosciences

HQ: United States Website
  • Description: Provider of biotechnology R&D focused on discovering and developing compounds against therapeutic targets in oncology and ophthalmology, including discovery of human antibodies against high-value targets; engages in alliances with other corporations.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full X-Body Biosciences company profile →
Tiziana Life Sciences Logo

Tiziana Life Sciences

HQ: United Kingdom Website
  • Description: Provider of biotechnology therapies focused on discovery and development of novel molecules in oncology and immunology, including Intranasal Foralumab (anti-CD3 nasal immunotherapy for neuroinflammatory and neurodegenerative diseases), Anti IL-6R mAb (TZLS-501) to reduce inflammation in idiopathic pulmonary fibrosis and autoimmune diseases, and Milciclib, a CDK-targeting cancer therapy.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Tiziana Life Sciences company profile →
Arcellx Logo

Arcellx

HQ: United States Website
  • Description: Provider of immune cell therapies, including anitocabtagene autoleucel, a CAR-T targeting BCMA for relapsed or refractory multiple myeloma (Phase 1); ACLX-001, a controllable ARC-T cell therapy with a bivalent SparX protein targeting BCMA for relapsed or refractory multiple myeloma; and ACLX-002, an ARC-SparX therapy targeting CD123 for relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Arcellx company profile →
Trubion Logo

Trubion

HQ: United States Website
  • Description: Provider of biopharmaceutical product candidates for autoimmune diseases and cancer, developing novel single-chain polypeptide proteins built with its SMIP custom drug assembly technology.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Trubion company profile →
BigHat Biosciences Logo

BigHat Biosciences

HQ: United States Website
  • Description: Provider of AI-guided antibody design and protein therapeutics via the Milliner platform integrating high-speed synthetic biology wet lab with machine learning to accelerate discovery and engineering; Reccy cloud-native LIMS/OS for instrument/robot control, scheduling, data management, and ML training; develops antibodies for oncology, inflammatory diseases, and immunology; partners with biopharma/biotech.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full BigHat Biosciences company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Acambis

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Acambis

2.2 - Growth funds investing in similar companies to Acambis

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Acambis

4.2 - Public trading comparable groups for Acambis

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Acambis

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Acambis

What does Acambis do?

Acambis is a provider of vaccine research, development and manufacturing for the prevention and treatment of infectious diseases in Europe and North America, offering ACAM2000, a smallpox vaccine for emergency-use stockpiling, and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets.

Who are Acambis's competitors?

Acambis's competitors and similar companies include X-Body Biosciences, Tiziana Life Sciences, Arcellx, Trubion, and BigHat Biosciences.

Where is Acambis headquartered?

Acambis is headquartered in United Kingdom.

How many employees does Acambis have?

Acambis has 1,000 employees 🔒.

When was Acambis founded?

Acambis was founded in 2010 🔒.

What sector and industry vertical is Acambis in?

Acambis is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Acambis

Who are the top strategic acquirers in Acambis's sector and industry

Top strategic M&A buyers and acquirers in Acambis's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Acambis?

Top strategic M&A buyers groups and sectors for Acambis include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Acambis's sector and industry vertical

Which are the top PE firms investing in Acambis's sector and industry vertical?

Top PE firms investing in Acambis's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Acambis's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Acambis's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Acambis's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Acambis include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Acambis's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Acambis?

The key public trading comparables and valuation benchmarks for Acambis include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Acambis for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Acambis with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Acambis's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Acambis with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Acambis's' sector and industry vertical?

Access recent funding rounds and capital raises in Acambis's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Acambis